Please provide your email address to receive an email when new articles are posted on . Injectable naltrexone showed a more favorable safety profile than its oral counterpart and other alcohol use ...

What is acamprosate used for? Acamprosate is commonly used to help people with alcohol use disorder who have already stopped drinking maintain their ability not to drink. Acamprosate may also be used ...

April 18, 2008 (Toronto, Ontario) — Current smoking and previous illicit drug use negatively affect alcoholism treatment outcomes, but acamprosate (Campral, Forest Laboratories [in the United ...

Acamprosate is a medication used in Europe and elsewhere to prevent relapse in alcoholics. New findings, in conjunction with previous research, indicate that acamprosate should be safe to take when ...

Acamprosate is used to treat alcohol dependence along with other rehabilitation therapy such as counseling and social support in people who have the intention of avoiding alcohol consumption.

September 13, 2010 — Acamprosate appears to be effective and safe for supporting continuous abstinence after detoxification in alcohol-dependent patients, according to the results of a systematic ...

Acamprosate reduces the number of patients being treated for alcoholism who return to drinking, according to a new review. The drug showed moderate benefits in trials when used in addition to non-drug ...

Please provide your email address to receive an email when new articles are posted on . The numbers needed to treat to prevent return to any drinking were 11 for acamprosate and 18 for oral naltrexone ...

Six different studies were performed. All information is provided in the Supplementary Information. Study 1: Screening panel for the mode of action of acamprosate. Study 2: Testing different salt ...

Acamprosate (Acmacal tab) is used to treat alcohol dependence along with other rehabilitation therapy such as counseling and social support in people who have the intention of avoiding alcohol ...

Acamprosate reduces the number of patients being treated for alcoholism who return to drinking, according to a new Cochrane Systematic Review. The drug showed moderate benefits in trials when used in ...